Development of commercial propositions for Respon Therapeutics in the management of chronic skin diseases

The objective of this report is to develop and analyse the commercial proposition of “Respon Therapeutics” in the management of chronic inflammatory skin diseases. “Respon Therapeutics” is a proprietary platform precision drug-delivery system developed by Professor Dang’s Laboratory for the manageme...

Full description

Bibliographic Details
Main Author: Yamini, Prashanth
Other Authors: Dang Thuy Tram
Format: Final Year Project (FYP)
Language:English
Published: Nanyang Technological University 2024
Subjects:
Online Access:https://hdl.handle.net/10356/177425